trimrx tirzepatide Oral GLP-1 | TrimRx

Reliable domestic supply

Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management, acts on the GLP-1 and GIP receptors to dramatically reduce appetite and improve metabolic function

Additionally, cinnamaldehyde's moderate lipophilicity (log P ~ 1.9) allows it to partition into the lipid bilayer, where its reactive aldehyde group interact with phospholipid headgroups and membrane-embedded proteins, increasing membrane fluidity and permeability to small ions

The glucagon paradox therefore represents a major conceptual advance in metabolic pharmacology

And existing FDA-approved treatments remain scarce